REG - Impact Healthcare - Dividend Declaration and Third Quarter Update

Impact Healthcare REITAnnouncement

20/10/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231020:nRST7305Qa&default-theme=true

RNS Number : 7305Q  Impact Healthcare REIT PLC  20 October 2023

The information contained in this announcement is restricted and is not for
publication, release or distribution in the United States of America, any
member state of the European Economic Area, Canada, Australia, Japan or the
Republic of South Africa.

 

This Announcement contains inside information for the purposes of Article 7 of
the UK version of EU Regulation 596/2014 (as incorporated into UK law by
virtue of the European Union (Withdrawal) Act 2018, and as subsequently
amended. Upon the publication of this Announcement, this inside information is
now considered to be in the public domain.

20 October 2023

Impact Healthcare REIT plc

("Impact" or the "Company" or, together with its subsidiaries, the "Group")

Dividend Declaration and Third Quarter Update to 30 September 2023

NAV growth from rent reviews and recent acquisitions with stable rental yields
and rent cover

HIGHLIGHTS

·      1.3% increase in NAV per share to 115.08 pence and 1.2% increase
in EPRA NTA per share to 114.38 pence

·      6.91% EPRA "topped up" Net Initial Yield, broadly flat from 6.95%
in June 2023

·      1.3% like-for-like increase in Property portfolio valuation to
£646.2 million

·      4.69% average increase in rent from 12 rent reviews

·      Contracted annual rent of £48.4 million

·      88.2% bed occupancy was stable for the period, and up over a
percentage point on December 2022

·    1.8x annual adjusted rent cover((1)) to 30 June 2023 that grew
during the third quarter of 2023 underlining the resilience of tenants

·      Collection of 99% of rent due for the 9 months to September 2023
with zero voids

·      21.0 years weighted unexpired lease term

·      27.0% gross loan to value (28.5% in June 2023), EPRA net LTV of
27.7% (27.6% in June 2023)

·    Group has currently hedged the interest rates on 98% (£175 million)
of drawn debt, with current average cost of drawn debt, including hedging and
fixed rate borrowings, of 4.47%

·    Dividend declared of 1.6925 pence per share, in line with our target
dividend of 6.77 pence for the year to 31 December 2023((2))

·      2.75% unaudited NAV total return for the period

NET ASSET VALUE / EPRA NTA

·      Unaudited net asset value ("NAV") as at 30 September 2023 was
£476.8 million, 115.08 pence per share. This represents an increase of £5.9
million (1.44 pence per share), against the 30 June 2023 NAV of £470.9
million, 113.64 pence per share.

o  The Investment portfolio has been independently valued by the Group's
external valuer Cushman & Wakefield.  The Group's EPRA "topped up" Net
Initial Yield at 30 September 2023 is 6.91% (30 June 2023: 6.95%) a marginal
improvement in the period reflecting strong rent cover.

 Pence per share                                        EPRA NTA  NAV
 Unaudited value per share as at 30 June 2023           113.08    113.64

 Revaluation gains/(losses) on investment properties    1.30      1.30
 Purchase of interest rate cap                          (0.42)    -
 Revaluation gain/(losses) on interest rate caps        -         (0.28)
 Net remaining contribution to reserves                 2.11      2.11
 Quarterly dividend for the period to 30 June 2023      (1.69)    (1.69)

 Unaudited value per share as at 30 September 2023      114.38    115.08
 Percentage change in quarter                           1.1%      1.3%

·      The NAV attributable to the ordinary shares of the Company is
calculated under IFRS, incorporating the independent portfolio valuation.

Summary balance sheet (unaudited)

                                 Sep-23   Jun-23   Mar-23   Dec-22
                                 £'m      £'m      £'m      £'m
 Property portfolio*             646.2    638.2    542.1    532.5
 Property Investments via loans  -        -        93.3     36.3
 Cash                            7.4      22.1     18.8     22.5
 Net assets/(liabilities)        1.9      1.4      (0.3)    (3.2)
 Bank loans                      (178.8)  (190.8)  (187.3)  (142.3)
 Net assets                      476.8    470.9    466.6    445.9
 NAV per share (pence)           115.08   113.64   112.60   110.17
 EPRA NTA per share (pence)      114.38   113.08   112.24   110.08
 Gross LTV                       27.0%    28.5%    28.3%    23.9%
 EPRA Net LTV                    27.7%    27.6%    22.6%    21.9%

*       Properties within the portfolio are directly owned by way of
freehold interest or long leasehold and are stated at the market value
provided by the external valuer and excludes the IFRS effects of guaranteed
rent reviews and initial lease rental payments.

PROPERTY VALUATION

·      The Group's Property portfolio was independently valued at
£646.2 million (30 June 2023: £638.2 million). This represents a 1.3% or
£8.1 million increase in value.

o  This like-for-like movement in value was in part driven by the increased
rent from the 12 rent reviews completed in the quarter at an average uplift of
4.69% per annum in line with the rental increase cap on these leases,
contributing an extra £0.3 million to contracted rent.

o  The EPRA 'topped up' net initial yield improved by 4 basis points to 6.91%
as at 30 September 2023 (30 June 2023: 6.95%), reflecting improvements in the
valuation on a sub set of the portfolio with consistently strong rent cover.

o  The Group invested £0.6 million in the quarter on asset management,
primarily the refurbishments at the Fairview and Mavern homes, operated by our
tenant Welford.

DIVIDEND DECLARATION AND TOTAL ACCOUNTING RETURN

·      The Board has today declared the Company's third interim dividend
for the year ended 31 December 2023 of 1.6925 pence per ordinary share,
payable on 24 November 2023 to shareholders on the register on 3 November
2023. The ex-dividend date will be 2 November 2023. This dividend will be paid
as a Property Income Distribution ("PID").

·      This is in line with the previously announced annual dividend
target of 6.77 pence per share for the year ending 31 December 2023((2)), a
3.5% increase over the 6.54 pence paid per ordinary share in dividends for the
year ended 31 December 2022.

·      The unaudited NAV total return for the period was 2.75%,
comprising the dividend paid in the period of 1.6925 pence per share and a
1.44 pence per share increase in NAV.

PORTFOLIO UPDATE

·      At 30 September 2023, the Investment portfolio comprised 140
healthcare properties((3)), of which 138 are care homes managed by 14
tenants((4)) on fixed-term leases of 20 to 35 years (no break clauses),
subject to annual upward-only Retail Price Index-linked rent reviews (with a
floor and cap at 2% p.a. and 4% p.a., respectively on 117 leases, and 1% p.a.
and 5% p.a. respectively on 21 leases). In addition, the Group owns two
healthcare facilities leased to the NHS with an annual CPI uplift. In total,
the Group had 14 tenants((4)) across its Investment portfolio.

·      Rent cover across our Investment portfolio remains strong at
1.8x((1)) for the 12 months to 30 June 2023. Tenants' detailed operational
performance reporting for the full quarter to September will be received at
the end of October 2023. Based on reporting from the tenants who report
monthly (as opposed to quarterly), which covers over 80% of the Group's
portfolio, we expect rent cover for the third quarter to improve on the first
half of the year.

·      Occupancy was stable at 88.2% at 30 September 2023, in line with
occupancy at 30 June 2023 (88.2%).

·      Contracted rent grew marginally to £48.4 million((5)) at 30
September 2023 (30 June 2023: £48.1 million) reflecting the increase from 12
rent reviews in the period.

·      Weighted average unexpired lease term across the Property
portfolio of 21.0 years as at 30 September 2023 (30 June 2023: 21.2 years).

·      The Group has varied the leases on seven homes previously leased
to Silverline and now being turned around by Melrose((4)). During the
turnaround period no rent is due on those homes. On the remainder of its
portfolio the Group charges rent quarterly or monthly in advance and has
received 100% (£11.5 million) of rent payments due for the quarter to 30
September 2023.  We have zero voids.

FINANCING

·      The Group's gross loan to value ("LTV") ratio was 27.0% as at 30
September 2023 (30 June 2023: 28.5%). The Group's EPRA LTV was 27.7% (30 June
2023: 27.6%).

·      The Group purchased a further £50 million interest rate cap in
the quarter at a cost of £1.76 million, which caps SONIA at 4.0% for two
years. The Group has now hedged the interest rates on 98% (£175 million) of
drawn debt. The current average cost of drawn debt, including hedging and
fixed rate borrowings, is 4.47%.

Notes:

((1)         ) Rent cover is our tenants' EBITDARM for the 12 months
to 30 June 2023 divided by 12 months' rent for the same period.  It excludes
"turnaround" and "immature" homes.  Immature homes being defined as homes
that are newly opened, or undergoing major capital improvement requiring
partial closure.  The rent cover calculation excludes eight properties that
are defined as turnaround or immature.

((2))       This is a target only and not a profit forecast. There can
be no assurance that the target will be met and it should not be taken as an
indicator of the Company's expected or actual results.

((3)         ) Includes exchanged and under construction assets.

((4))       Belmont, Careport, Carlton Hall, Electus Healthcare, Holmes
Care, Maria Mallaband Countrywide Group, Minster, Croftwood and Melrose
(Minster and Croftwood are subsidiaries of Minster Care Group and Melrose is
an affiliate), NHS Cumbria, Optima, Prestige, Renaissance and Welford.

((5)         ) Contracted rent includes rent due, or passing rent,
alongside; future committed rent from contracted capital projects and forward
funded developments, rent associated with deferred payments, contractually
exchanged property acquisitions and post tax interest income from investment
in properties by way of a loan.

 

FOR FURTHER INFORMATION, PLEASE CONTACT:

 Impact Health Partners LLP                                                             Via H/Advisors Maitland
 Andrew Cowley
 Mahesh Patel
 David Yaldron

 Jefferies International Limited                                                        +44 20 7029 8000
 Tom Yeadon                                    tyeadon@jefferies.com
 Neil Winward                                  nwinward@jefferies.com
 Ollie Nott                                    onott@jefferies.com

 Winterflood Securities Limited                                                         +44 20 3100 0000
 Neil Langford                                 neil.langford@winterflood.com
 Joe Winkley                                   joe.winkley@winterflood.com

 H/Advisors Maitland (Communications advisor)                                           +44 7747 113 930
 James Benjamin                                impacthealth-maitland@h-advisors.global
 Rachel Cohen

 

The Company's LEI is 213800AX3FHPMJL4IJ53.

 

Further information on Impact Healthcare REIT is available at
www.impactreit.uk (http://www.impactreit.uk/) .

 

NOTES:

Impact Healthcare REIT plc is a specialist and responsible owner of care
homes and other healthcare properties across the UK. Elderly care is an
essential service and demand for it is high and continues to grow as
the UK's population gets older. We work with our tenants so we can grow
together and help them care for more people, while continuing to improve our
homes for their residents.

 

We take a long-term view and look to generate secure and growing income. This
has allowed us to provide our shareholders with attractive and rising
dividends and the potential for capital growth.

 

The target total dividend for the year ending 31 December 2023 is 6.77 pence
per share((2)), a 3.53% increase over the 6.54 pence in dividends per ordinary
share for the year ended 31 December 2022.

 

The Group's Ordinary Shares were admitted to trading on the main market of the
London Stock Exchange, premium segment, on 8 February 2019. The Company is a
constituent of the FTSE EPRA/NAREIT index.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NAVNKCBPABDDNKD